Stifel Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Buy |
26,435
+2,725
| +11% | +$31.6K | ﹤0.01% | 3040 |
|
|
2025
Q1 | $207K | Buy |
23,710
+2,713
| +13% | +$23.7K | ﹤0.01% | 3175 |
|
|
2024
Q4 | $302K | Buy |
20,997
+4,628
| +28% | +$66.5K | ﹤0.01% | 2959 |
|
|
2024
Q3 | $370K | Buy |
16,369
+5,890
| +56% | +$133K | ﹤0.01% | 2851 |
|
|
2024
Q2 | $204K | Buy |
10,479
+2,479
| +31% | +$48.2K | ﹤0.01% | 3109 |
|
|
2024
Q1 | $300K | Buy |
8,000
+2,066
| +35% | +$77.5K | ﹤0.01% | 2910 |
|
|
2023
Q4 | $332K | Buy |
+5,934
| New | +$332K | ﹤0.01% | 2790 |
|
|
2023
Q3 | – | Sell |
-4,733
| Closed | -$264K | – | 3406 |
|
|
2023
Q2 | $264K | Buy |
4,733
+73
| +2% | +$4.08K | ﹤0.01% | 2905 |
|
|
2023
Q1 | $260K | Sell |
4,660
-16,868
| -78% | -$941K | ﹤0.01% | 2904 |
|
|
2022
Q4 | $784K | Buy |
21,528
+3,996
| +23% | +$146K | ﹤0.01% | 2179 |
|
|
2022
Q3 | $499K | Sell |
17,532
-5,329
| -23% | -$152K | ﹤0.01% | 2434 |
|
|
2022
Q2 | $1.03M | Buy |
22,861
+821
| +4% | +$37.1K | ﹤0.01% | 1967 |
|
|
2022
Q1 | $1.68M | Buy |
22,040
+3,927
| +22% | +$299K | ﹤0.01% | 1742 |
|
|
2021
Q4 | $2.7M | Buy |
18,113
+13,409
| +285% | +$2M | ﹤0.01% | 1414 |
|
|
2021
Q3 | $685K | Sell |
4,704
-287
| -6% | -$41.8K | ﹤0.01% | 2377 |
|
|
2021
Q2 | $978K | Sell |
4,991
-7,691
| -61% | -$1.51M | ﹤0.01% | 2120 |
|
|
2021
Q1 | $2.3M | Buy |
12,682
+5,755
| +83% | +$1.04M | ﹤0.01% | 1437 |
|
|
2020
Q4 | $981K | Buy |
+6,927
| New | +$981K | ﹤0.01% | 1857 |
|
|
2020
Q1 | – | Sell |
-2,709
| Closed | -$207K | – | 3082 |
|
|
2019
Q4 | $207K | Buy |
+2,709
| New | +$207K | ﹤0.01% | 2748 |
|